ObiddilQ.
'Ihis study sought to establish the chemosensitivity cd patkats witb chroak hea failure. i%ukgmd.
The Patients with chronic heart failure are often limited % exertional dyspnea and exercise intolerance. Although the survival of these patients has improved with vasodilator therapy, especially with angiotensinconvct-ting enzyme inhibitors (l-4) . the symptoms remain debilitating. The precise mechanisms underlying the: symptoms are not known (5.6). There is little correlation between exerciw tolerance and resting hem@-namic val ;ables (7, 8) . Both pulmonary and peripheral facton (9), including skeletal myopathy (10-12) and Impaired peripheral blood Bow (13), may play a role in the genesis of these symptoms. The proportional increase in ventilation with work rate, oxygen consumption and carbon dioxide output is seen in patients with chronic heart failure during exercise as it IS in normal subjects (14 15). This finding suggests that the stimulus to exercise ventilation may be humoral and that arterial chemoreceptors may play ;I central role. It has been documented previously that in normal subjects, the ventilatory response to cxcrcice correlates positively with chemosensitivity (16.17). As a corollary to this, the increased vcntilatoty response to exercise seer. in patients with chronic he:irt failure and characterized by the steeper regression slog relating minute ventilation to carbon dioxide output may be related to an increased chemosensitivity. On a more theoretic basis. it has also been suggested (18) that the generalized neurohormonal activation in chronic heart failure may not only be linked to a reduced input from inhibitory baroreceptors, but may also be caused by an increased input from excitatory chemoreceptors. On the basis of these considerations, we hypothesized that the sensitivity of chemoreceptors to afterial blood gases may he reset and may in part mediate the exercise hyperpnea seen in this condition. The purpose of this study was, therefore, to examine the chemosensitivity of patients with chronic heart failure, which hitherto has MM been evaluated, and to assess its 
Methods
Subjects. Thirty-eight patients *Gth chronic heart failure between 40 and 75 years of age (mean age ['SE] ho.2 ? 1.3 years: 35 men. 3 women) participated in the study. Patients with a known history of pulmo?dT and ncurologic disease were excluded from the study. AL patients had been in helit failure for >3 months. They were all treated with diuretic drugs, and most received angiotensinconvertinp enzyme inhibitors. Nineteen patients were in New York Heart Association functional class II. and 16 in class III. No patient was limited by angina. Patient characteristics are summarized in Table I . A control group of 15 healthy subjects (31 10 73 years old, mean age 54.9 2 3.0 years; 11 men. 4 women) was also studied.
Hypoxic and peripheral hypercapnic chernosensitivit)l. bolh mediated by the carotid chemoreceptors. was assessed at rest in all subjects. The first I5 consecutive patients with chronic heart failure recruited into the study also had these asses+ merits made during mild exercise on a cycle ergometer (Tunturi) at 15 W for 10 min on two separate occasions lo evaluate the change in chemosensitivity on exercise. A bed exlerna' work rate ~'2% used based on the obscrvatilln that for a parlicular work Kite. patients with chronic heart failure have a higher ventillitory rc?lponsc: than normal subjects (14). In addilion, ccnrral hypercapnic chemosensitivity was assessed in IO control subjects and 3 patients to assess the role of central (medullarv) chcmorcccplnrs. AH rubjccls performed rdrdiopulmonan: cxerciwz te$ling it) as~"i% the vcnlilaton response to exerciw. Subjects were told 14) avoid caffeinated products on the morning of the tesls. The study had been approved by Ihe local clllin commil~ee. and all sibjccta gave written informed consent.
Transient hypoxic wntilatwy mponse ttst. Thcrc are three principal methods of asxcsing hypoxic chemcMnsidvi9 using steady slate (IY). progressive (X.21) and transient (22) hypoxia. respectively. The absolute values obtained from each method arc different. hut relatively. fhey reflect the same indexes of chcmwn$itiviry (23.24). The transient hypoxic method was chosen in this study for practical ;1, 1 safety reasons because patienls were not subjected to 1 olonged episodes of hypoxia. cspeciallv during exercise. and Ine depressant effects of prolonged hypoxia on central respiratory drive are also avoided.
The transient hypoxic chemosensitivity tesr was performed while tuhjects were qieaierl and after a period of quiel hreathing. Each subject wore a nose clip and.breathcd through a pneumatic respiratory valve (Innovision). which separated the expir-te from the inspirate. The inspilate porr wz further connected 10 a T-valve placed behind the subject. and, depending on the position of the T-valve. the subject breathed either room air or pure nitrogen from a 4-liter reservoir bag that was quietly refilled from a gas cyliqder containing pure nitrogen. Minute ventilation was measured breath by breath using a heated pneumotachograph. and continuous monitoring of oxygen and carbon dioxide was done at the mouth by w spectrometry (Amis 2000, Innovision). The pneumolachomeler and mass spectromeicr were calihrzted &fore each test. Arterial oxygen saturation was measured using a pulse oximetcr (model N-IOOE. Nelkor), set at fast mode uith a response time of 2 to 3 s and a lightweight ear probe clipped gently on the subject's right earlobe. After the subject breathed room air for several minutss. the T-valve was turned surreptitiously during the expiralory phase of the previous brealb so that pure nitrogen was inhaled for two to eight breaths. This was repeated IO lo I5 times to provide a wide range of arterial oxygen saturations from 70% to IO%. with -3min intervals of air breathing between eizres to dlow anerial oqp saturation and end-tidal carbon dioxide to return to the subject's baseline. The maximal minute ventilation after each peti of nitrogen inhalation was obtained by aleraging the two largest consecutive breaths. We found t!w two-breath period optimal in maintaining sensitivity and r:praiwbility of the transient hypcrxic test as did Edelman et al. (3). The timal ventilation was then plotted against th: lowest arterial oxygen saturation reached for eveT period of nitrogen inhalation. The transient hypoxic chemoscnsitivity was ohtaincd as the slope of the best-fit line that related ventilation IO arterial oxygen saturation. calculated by loa+squarch linear regression analysis and expressed in terms of liters per minute per percent oxygen saturation (litcrsimin per BSao,). For the transient hypoxic test during cxercisc. on average, only six episodes of transient hypoxia were @en in view of the duration of the exercise. A delay of 3 rnlhl after the onset of exercise was given before the hypoic chcmosensitivity testing to allow steady state (X,27). For safety reasons, the degree of arterial oxygen desaturation was deliberately kept X30%. All patients were monitored clcctrocardiographically during exercise. Siwth carbon dioxide ventilatoy response test. Peripnera! hypercapnic chemosensitivity was axwssed using the single-breath carbon dioxide test as described by McClean et al, (28) . The apparatus includingthe T-valve was the same as that described before. A smaller 2-liter reservoir hag was used. which was quietly refilled after each inhalation with a gas mixture containing 139 carbon dioxide in air. After a period of quiet breathing, the T-valve was turned during the expiratoq ph;w of the previous breath so that the subject inhaled a single breath of 13% carbon dioxide in air. On average, IO breaths were administered at -2-min intervals. As before. minute ventilation was measured. with continuous monitoring of carbon dioxide done at the mouth. The mean minute ventilation of the preceding five breaths before the stimulus carbon dioxide breath was calculated and taken as the control ventilation [v(C)]. The mean end-tidal fraction of carbon dioxide of these breaths was also cakulatcd and taken as the control end-tidal fraction of carbon dioxide [Ft~co,(C)]. The rcspmx ventilation after the stimulus catin dioxide hreath [v(S)1 was calculated by averaging the two largest conxcutive breaths but, unlike before, within 20 z after the stimulus breath. Breaths beyond this time limit were assumed to be affected by central chemoreceptors and therefore excluded from analysis (28). The end-tidal carbon dioxide concentration of the stimulus breath was considered the stimulus end-tidal fraction of carbon diixide [FtTcx)JS)l, The single-breath ca&m dioxide response was calculated using the previous variables as follows:
where P, is the atmospheric pressure (mm Hg), and 47 is the saturated water vapor pressure (mm Hg). The mean of 10 responses was considered the subject's single-breath carbon dii response at rest and expressed in liters per minute per millimeter Hg (liters/min per mmHg). For the IO-min exercise period at 25 W on the cycle ergometer, an average of six single breaths of carbon dioxide were administered at shorter time intervals in view of increased minute ventilation and circulation during exercise. These were given 3 min after the onset of exerck to allow steady state. m dbGdc rdn~!&@ ttebn&. Central hypercapnit chemasensitivity was assersed using rebreathing of carbon dioxide (ZY) . During the tot. expired carbon dioxide is constantly returned to Ihc lungs, and as carbon dioxide accumulirtes. thih provides ti progrcs\ive carbon dioxide stimulus lo vrntilation. After ti period of quiet breathing, subjects rebreathed through a &liter hag containing a gas mixture of 7ci carbon diosidc in oxvgcn for 1 min; the test was stopped sooner tf they wcrc too hrcathlrL3 IO continue or if P~-T(I)~ exceeded Ill'r. II has hecn shoun (?Y) that by rehreathingof 7% carbon dioxide (which approximates IO venous PC o?) in oxygen. a Pco, equilibrium is developed rapidly in the mixed venous blood. arterial blood. gas in the lung and gas in the breathing bag. Thus. Ihe PC o2 in any one of these compartments is rcpresenlativc of the other compartments. including the brain tissue. With thr high oxygen concentration. the peripheral hypercapnit respnsc is known IO be very small or negligihle (3U.31). Minute ventilation was measured breath by breath. and continuous monitoring of oxygen and carbon dioxide was done at the mouth by mass spectrometry. The central hypercapnic chemuscnsitivity was obtained irs the slope that related minute ventilation to PETCO~ calculated by linear regression analysis ,md expressed in terms of liters per minute per millimeter Hg (literslmin prr mm Hg). We did not perform this test during exercise because of the uncertainties of Pco, equilibrium during exercise in all the compartments (nixed venous blood. arterial bkwd, gas in the lung and gas ill the breathing bag) using the same mixture of 7?i carbon dioxide in oxygen.
Studies of reproducibility. The transient hypoxic. singlrbreath carbon dioxide and rehreathing carbon dioxide tests were repeated in seven healthy control subjects and tive patients with chronic heart failure lo assess reproducibility and the coefticient of variation. There was g& agreement he-!ween repeated mcasuremcnts (r = 11.93, O.hY and 0.97, respectively. p c: 0.0s for all three tests), with the mean coe@cient nf variation of the respective tests being 21.4 2 3.w (. 21.0 2 4.Y? and 14.6 2 4.4%. accordingly, comparable to other studies (24,28,2Y) . Similarly. the mean value of the respective tests in our control subjects compared favorably with previous data (24.25,28.2Y).
CanGopulmma~ exercise testing, Cardiopulmonary exercise testing was performed in all subjects on a separate day IO determine the exercise ventilation. All exercised to exhaustion (respiratory exchange ratio > 1.1) using the Bruce protocol (32). with the addition of a "stage 0" at 1.0 mph and 5% gradient tor the patients with chronic heart failure. Respiratory gas exchange analysis was carried out by means of a respiratory mass spectrometer (Amis 2OtKL Innovision) using the inert gas dilution technique (33). The slope of the regression line relating minute ventilation to carbon dioxide output was used as an index of the vcntilatory response to exercise (IS).
Statistieal analysis. Results are presented as mean value 2 SE. Two-tailed Student I test was used where appropriate to asess the significance of results. The relation between variables was assessed using linear regression analysis; p < 0.05 was considered significant. 
Results
Cardiopulmoaory exe&se ttsting Mean age. height and weight of control subjects and patients with chronic heart failure did not differ significantly (Table I ). Also shown in Table I , patients with chronic heart failure had a lower maximal oxygen consumption (p < O.oOnI ) and higher ventilatory response to exercise as judged by the higher ventilationcarbon dioxide output regression slope compared with that fol control subjects (p < 0.0001). There was no significant difference in maximal oxygen consumption (16.4 2 0.X vs. 17.3 2 2.3 ml/kg per min). ventilation-carbon dioxide output rcgression slope (38.13 z 1.70 vs. 34.M 5 3.40) or left ventricular ejection fraction (27. I 2 2.8 vs. 22.7 2 4.5%) between patients with chronic heart failure from ischemic heart disease and idiopathic dilated cardiomyopathy who participated in the study.
Hypoxic cbemoscasitivity. Figure 1 shows a significanrly higher transient hypoxic venrilatory response in patients with chronic heart failure (0.707 ? 0.076 litenimin per %aol) than in control subjects (0.293 % 0.056 lilrrs/min per 'iSac),). When the results of the transient hypoxic ventilarory test were analyzed separately for patierlts with chronic hearl failure from ischemic heart disease and idiopathic dilated cardiomyopathy. there was no significant difference between the two groups (0.642 ? 0,088 vs. 0.819 ? 0.14 literslmin per Mao,, p = 03).
H-pie rkao6cpsitivity. Tbe peripheral hypercapnic chemosensitivity was higher in patients with chronic heart failure (0.388 2 0.04 vs. 0.310 2r 0.051 litersimin per mm Hg). but this did not reach statistical significance (Fig. 2) . On the amtrary. when central hypercapnic chemosensilivity was assessed in 25 of the patients with chronic heart failure. there was a significant difference between patients and conboA subw (3.15 2 0.41 vs. 2.02 2 025 lite&nin per mm Hg. p = 0X5) 27.5 t 3.6%) compared with all patients with chronic heart faibc as a group. As shown in Table 7 . the tr,ln.Gent hypoxic Table 2 . the peripheral hypcrcapnic chemoscnsitivity was also augmented during cxcrcise in control subjects and patients. but there was no significant ?ifferenic between the two groups. When the hypoxic chemosensitivit! I'nCdwrLX! during mild exercise was cotrrlated with ventilation-carhjn dioxide output regression slope. the relation ktween these two variab!rs remained intact. with a correlation coelTicient of 0.41 (p = 0.024). A weak association hctween the: Gngle-breath czrhon dioxide response during exercise and venttlation-carhon dioaidc output regression slope was also seen (r = 0.U. p = O.DY).
Discussion
General findings. Little is known about chcmosensitivity in chronic heart failure. It has been documented th3t centrar hypercapnic chemoser,:,itivity is enhanced in patients with chronic heart failure with central sleep apnea. but hypoxic chcmosensitivity was not studied (34). We demonstrated in the present study that there is increased hvpoxs and central hypercapnic chemosensitivitv in patients with chronic heart failure. We showed that patients in functional class 111 had a higher chemosensitivrty than those in class II. although thiswas not statistically significant with respect to hypoxic chcmoscnsitivity. The lack of diflerentiation may be because there is much overlap in hypoxic ch;mosonsitivity Ltween patrents in functional classes II and II: or perhaps h.Ypoxic chemosensitivity is less associated with the functional capacity of patients. It has to be acknowledged that even in normal subjects. both hypoxlc and hypercapnic chemosensitivity may va:y considerably between subjects (35). However, the central hypercapnir chemosensitivity was significanth higher in ,p&ients in a I ighcr functional class and may therefore relate more to the severi!! of chronic heart failure.
The absence of a significant increase in single-breath carbon dioxide response in patients with chronic heart failure ic surprismg although no; totally unexpected. The single-breath carbon dioxide responx test measures the pcr;pheral hypcrcapnic chemosensitivity. Functional hypercapnic chemosens; tivity is predominantly mediated by the central citemurczep ton. Some studies (.W) have shown that the peripheral hypercapnic chemt~nsitivity recounts for ortry chwt one tenth of overall carbon dioxide chen~naitivity.
hlechmisrns causing bcrtwud elnmomsitii. There arc several possible mechanisms causing increased hypoxic chemosensitivity in patients with chronic heart failure. It is recognized that there are neurohormonaf changes (.%.37) in patients with chronic heart failure. and these include increased catecholamine Icvek. Catecholamines are known lo potentiale che~nsitivity (38.39). Peripheral bland flow is also known lo hc rcduccd in chronic hrart failure (13). and this may be related to redaced cardiac:~utput or tncreawd vasomotor tone. it has been prcvious!y +uggcsted that a decrcasc ill chemorcceptor Mood How. causing an ;schemic hvxoxia. may alw mcdiat.: an increay: in chemotinGvity (40). Mechanisms causing altered central hyxercapnic chcmtnensitivitv arc ;F3rc obscure. Alteration in central nrurogenic input or si;nab from muscl: erpcrccepton (41.42) may induce ch;tlgC\ in central hypercapnic cnenloscnsitivrty. Mtcmativcly. signals from muscle ergoreceptors may feed directly into the re\piratoF control centers. causmg ceMral augmsntJtion of both medu'tary and carotid chemoreceptor input. We have recently shoun that !he contribution of ergorcceptors to the vcntilato? rcsponsc to cxercix IS higher in patients with chronic heart failure than in control subjects (43). Early lactic acidosis during exerciw may reduce the buffering ability ir. patients with chrouic heart failure aith consequent inr:e;ud cScmorcceptor acti+ but this cannot explain the increased chemocensitivity at rest. Perhaps the interaction of carbon dioxide with other ventitatory control mechanisms may offer clue.. It may b: that the respiratory control centers are similarly and nluthpcifically more responsive to vdrioiis stimuli includinu carbon dioxide and exercise (4).
ReMioll llellmn cbcmoscnsittiIy ad excmise wltilhoa. The role of chemcrsen~itivity in mediating the ventilalory rcsponw: to cxrrcice is not known in chronic heart failure. !n normJ sutjrcts. it has been shown in one study that carbon dioxide &mtKcnsitivity. a? measllrcd by the rebrcathing method, is related to the ventilato5 response to exercise (In). In another study. exercise ventilation has been shown to be pos*'ivrly corr&a~ed with both hyprxic and hyvrcapnic chemosensitivity in healthy subjects (17). The mechanisms @ which chsmorzceptors may mediate exercise hyperpnra remain unckar. becz~use there is litttc Ytituation in arterial Mood gscs. the puurtive stimuli. dui,ng exercise. Suggested rtechanisms include an increased gain in chermrsensilivity during cxrrcisc (4S.a). Augment,.ion in chcmosemitivity during exercise has been well documented in normal subjects (38.47). In other words. for a given partial pressure: of arterial blood gases. it represenls a higher stimdus to ventitalion than otherwise, had the chemosensrtivity not ken enhanced. Thus. the absence of significant hypoxemia or hypercapnia does n01 exclude the existence of increard chemoxnrilivity.
In uur study, we showed an increase in rest hypoxic and cenlral hyprcapnic chcmosensitivity in patients with chronic heart failure crbmpared with that in nrrmal subjects. There WAS ab, a significant degree of correlation between resting chemoseflritivity and rhe rentilatory responu IO exercise. Hypxxic and hvprcapnic (at least the peripheral component) chemosensiti& were shown IO be augmented in p&ems with chronic heart failure during excrcisc. * augmentation in chemosensitivity during exe&c may be explained by a further increase in catccholamiocs during cxercisc i-38). ekzatron of arterial potGum level (48) Shaw et al. (24) . the transient method can give as such oscillations as a mechanism by which chemoreceptors good an index of hypoxic chemosensitivity as the progressive method. may a&t exercise hyperpnea has been documented previously (4950). In chronic heart failure, the increased ventilatory response to exercise is often attributed to the increase in dead space ventilation (51). However, it remains 10 k answered how this dead space is sensed by the body, particularly if arterial blood gases remam little changed in chronic heart failure (52). Increased physiologic dead space and ventilationperfusion mismatch may well increase the amplitude of oscillations in blood gases that is sensed by chemoreceptors. They may therefore also by important in mediating the effects of increased dead space and ventilation-perfuaior. mismatch in chronic heart failure.
Coeelns~ The increase in chemosensitivity may serve as a compensatory mechanicm producing an increase in ventilatory response during exercise and thereby preserving blood g* homecntasis. including maintaining arterial oxygen concentration. In fact. it has been shown (53) that increasing inspired oxygen concentration during exercise improves breathlessness and reduces minute ventilation in these patients. Other investigators (54) have reported mechanisms such as increased erylhropoiesis that directly improve arterial oxygen content In chronic heart failure patients to compensate for reducrd systemic arterial oxygen deliver).
In conclusion. there is increased hypoxic and central hypercapnic chemosensitivity in patients with chronic heart failure. Both hypoxic and hypercapnic chemosensitivity appear to correlate well with the ventilatory response to exercise. Although this association does not necessarily mean causation, arterial chemoreceptors may mediate the exercise hyperppea seen in patients with this condition. The control of ventilation during exercise is complex, probably more so in chronic heart failure. Therefore, although increased chemosensitivily may play a role in the exercise hyperpnea in chronic heart failure, there are likely IO be other factors involved. Furthermore, although this study shows the association between enhanced chemosensitivity and the increased ventilatory response to exercise, it should be emphaswd that the latter is not synonymous with the sensation of dyspnea. It thus remains to be seen whether drugs that suppress chemosensitivity, such as mild opiates (55). would be of therapeutic benefit in retieving the debilitating symptoms of breathlessness in chronic heart failure. From the results of the first 15 consecutive patients with chronic heart failu e. we found that the hypoxic chemosensitivity was significantly higher in chronic heart failure, kth at rest and during exercise. We therefore discontinued assessing the exercise chemosensitivity of the remaining patients. primarily kcause hypoxia during exercise was unpleasant to patients and had a certain associated risk. These 15 patients had similar age. exercise capacity, tadionuclide ejection fraction and resting chcmosensitivity compared with all the patients with chronic heart failure we studied as a whole. Despite only a randomI}-chten subgroup of subjects having had the carbon dioxide rebreathing test. we were able to demonstrate that the central hypercapnic chemoscnnsitivity was increased in patients with chronic heart failure. be did not attempt to measure central hypercapnic chemosnsitivity during exercise., for the reawns stated, which may have otherwise added more information lo our St+. Finally. because of the obvious lin+ation of using ventilatory changes to quantitatc chemosensir;vity. it is not possible to distinguish whether the increased ventilatory responses to hypoxia or hypercapma are solety retated to an increased gain in intrinsic chemoreccptor tunction or whether they reflect the sitered kinetics caused by an increased dead space in heart failure. Howcber. 3% discussed earlier. there are several abnormalities in chronic heart failure that may cause an increased chemosensitivity. thus making it unlikely that the results in this study arc largely caused by an increased dead spuce. Furthermore, there is a fundamental difference between the ventilatory response to metabolic changes during exercise and the vc,ltilatory response to hypo!.ia or hypercapnia. as in the tests of chemosensitivity, in relation to dead space. The ventilatory rqonse lo exercise represents a response to an endogenous load, whereas rhe latter represents that to an external stimulus. An increased dead space may actually diminish the level of the external stimulation reaching the arterial chemoreceptors. That there was an increase in chemosensitivity thcrcfore suggests that there is an inherent change in chemoreceptor function.
